Consensus Recommendations on Rater Training and Certification

| December 7, 2014 | 0 Comments

West_NovDec_2014_Artby The CNS Summit Rater Training and Certification Committee: Mark D. West; David G. Daniel, MD;
Mark Opler, PhD, MPH; Alexandria Wise-Rankovic, PhD; and Amir Kalali, MD
Mr. West is Principal Consultant with Innovum Research, Las Vegas, Nevada (was with ePharmaSolutions, Plymouth Meeting, Pennsylvania, at the writing of this article); Dr. Daniel is Senior Vice President, Chief Medical Director, Bracket Global LLC and is with the Department of Psychiatry and Behavioral Sciences, George Washington University, McLean, Virginia; Dr. Opler is Chief Scientific Officer, Founder, ProPhase LLC, New York, New York; Dr. Wise-Rankovic is Vice President, CNS Clinical Development, INC Research, Raleigh, North Carolina; and Dr. Kalali is Professor of Psychiatry, University of California, San Diego, and Vice President, Global Head, Neuroscience Center of Excellence, Quintiles, San Diego, California.

Innov Clin Neurosci. 2014;11(11–12):10–13

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , ,

Category: Drug Development, Neurology, Psychiatry, Trial Methodology

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.